Increased chromosome-type chromosome aberration frequencies as biomarkers of cancer risk in a blackfoot endemic area

Cancer Research

Volumn 59, Issue 7, 1999, Pages 1481-1484

  Liou, Saou Hsing ^a   Lung, Jia Chyi ^a   Chen, Yeong Hwang ^a   Yang, Tsann ^a   Hsieh, Ling Ling ^d   Chen, Chien Jen ^b   Wu, Trong Neng ^c  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c Dis Survlnc and Quarantine Service   (Taiwan)

^d CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ARTICLE; BLACKFOOT DISEASE; BLOOD CULTURE; CANCER RISK; CHROMOSOME ABERRATION; CHROMOSOME BREAKAGE; CYTOGENETICS; EARLY DIAGNOSIS; ENDEMIC DISEASE; GENE FREQUENCY; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; SISTER CHROMATID EXCHANGE;

ADULT; AGED; ARSENIC POISONING; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHROMOSOME ABERRATIONS; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASMS; SISTER CHROMATID EXCHANGE; TAIWAN; WATER POLLUTANTS, CHEMICAL;

EID: 0033118454     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Carrano, A. V. Chromosomal alterations as a marker of exposure and effect. J. Occup. Med., 28: 1112-1116, 1986.
2. Wen, W. N., Lieu, T. L., Chang, H. J., Wu, S. W., Yau, M. L. and Jan, K. Y. Baseline and sodium arsenite-induced sister chromatid exchanges in cultured lymphocytes from patients with blackfoot disease and healthy persons. Hum. Genet., 59: 201-203, 1981.
3. Ostrosky-Wegman, P., Gonsebatt, M. E., Montero, R., Vega, L., Barba, H., Espinosa, J., Palao, A., Cortinar, C., Garcia-Vargas, G., del Rozo, L. M., and Cebrian, M. Lymphocyte proliferation kinetics and genotoxic findings in a pilot study on individuals chronically exposed to arsenic in Mexico. Mutat. Res., 250: 477-482, 1991.
4. Lerda, D. Sister-chromatid exchange (SCE) among individuals chronically exposed to arsenic in drinking water. Mutat. Res., 312: 111-120, 1994.
5. Nordenson, I., Beckman, G., Beckman, L., and Nordstrom, S. Occupational and environmental risks in and around a smelter in northern Sweden. II. Chromosomal aberrations in workers exposed to arsenic. Hereditas. 88: 47-50, 1978.
6. Liou, S. H., Jacobson-Kram, D., Poirier, M. C., Nguyen, D., Strickland, P. T., and Tockman, M. S. Biological monitoring of fire fighters: sister chromatid exchange and polycyclic aromatic hydrocarhon-DNA adducts in peripheral blood cells. Cancer Res., 49: 4929-4935, 1989.
7. De Klein, A. Oncogen activation by chromosomal rearrangement in chronic myelocytic leukemia. Mutat. Res., 86: 162-172, 1987.
8. Heim, S., and Mitelman, F. Nineteen of 26 cellular oncogenes precisely localized in the human genome map to one of the 83 hands involved in primary cancer specific rearrangements. Hum. Genet., 75: 70-72, 1987.
9. Hagmar, L., Brogger. A.. Hansteen, I. L., Heim, S., Hogstedt, B., Knudsen, L., Lambert, B., Linnainmaa, K., Mitelman, F., Nordenson, I., Reuterwall, C., Salomaa, S., Skerfving, S., and Sorsa, M. Cancer risk in humans predicted by increased levels of chromosomal aberrations in lymphocytes: Nordic study group on the health risk of chromosome damage. Cancer Res., 54: 2919-2922, 1994.
10. Bonassi, S., Abbondolo, A., Camurri, L., Dal Pra, L. De Ferrari, M., Degrassi, F., Forni, A., Lambert, L., Lando, C., Padovani, P., Sbrana, I., Vecchio, D., and Puntoni, R. Are chromosome aberrations in circulating lymphocytes predictive of a future cancer onset in humans' Preliminary results of an Italian cohort study. Cancer Genet. Cytogenet., 79: 133-135, 1995.
11. Hagmar, L., Bonassi, S., Stromberg, U., Brogger, A., Knudsen, L. E., Norppa, H., Reuterwall, C., and the European Study Group on Cytogenetic Biomarkers and Health. Chromosomal aberrations in lymphocytes predict human cancer: a report from the European study group on cytogenetic biomarkers and health (ESCH). Cancer Res., 58: 4117-4121, 1998.
12. Tseng, W. P., Chu, H. M., How, S. W., Fong, J. M., Lin, C. S., and Yeh, S. Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan. J. Natl. Cancer Inst. (Bethesda), 40: 453-463, 1968.
13. Chen, C. J., and Wang, C. J. Ecological correlation between arsenic level in well water and age-adjusted mortality from malignant neoplasms. Cancer Res., 50: 5470-5474, 1990.
14. Chen, C. J., Chuang, Y. C., Lin, T. M., and Wu, H. Y. Malignant neoplasms among residents of a blackfoot diseases-endemic area in Taiwan: high-arsenic artesian well water and cancers. Cancer Res., 45: 5895-5899, 1985.
15. Chen, C. J., Chuang, Y. C., You, S. L., Lin, T. M., and Wu, H. Y. A retrospective study on malignant neoplasms of bladder, lung and liver in blackfoot disease endemic area in Taiwan. Br. J. Cancer. 53: 399-405, 1986.
16. Bates, M. N., Smith, A. H., and Hopenhayn-Rich, C. Arsenic ingestion and internal cancers: a review. Am. J. Epidemiol., 135, 462-476, 1992.
17. Liou, S. H., Gu, T. L., and Chen, C. J. Hypersensitivity to mitomycin C-induced sister chromatid exchange as a biomarker of past exposure to arsenic. Cancer Epidemiol. Biomark. Prev., 5: 103-107, 1996.
18. Hsu, Y. H., Li, S. Y., Chiou, H. Y., Yeh, P. M., Liou, J. C., Hsueh, Y. M., Chang, S. H., and Chen, C. J. Spontaneous and induced sister chromatid exchanges and delayed cell proliferation in peripheral lymphocytes of Bowen's disease patients and matched controls of arseniasis-hyperendemic villages in Taiwan. Mutat. Res., 386: 241-251, 1997.
19. Hulka, B. S. Overview of biological marker. In: B. S. Hulka, T. C. Wilcosky, and J. D. Griffin (eds.), Biological Markers in Epidemiology, pp. 3-15, Oxford: Oxford University Press, 1993.
20. Lambert, B., Lindblad, A., Holmberg, K., and Francesconi, D. The use of sister chromatid exchange to monitor human population for exposure to toxicologically harmful agents. In: S. Wolff (ed.), Sister Chromatid Exchange, pp. 149-182. New York: Wiley, 1982.
21. Weinberg, R. A. The genetic origins of human cancer. Cancer (Phila.), 61: 1963-1968, 1988.